ELCC 2021 | Treating cancer during the COVID-19 pandemic

Federico Cappuzzo, MD, PhD, AUSL della Romagna, Ravenna, Italy, talks on the risks of COVID-19 infections in patients with cancer, outlining the implications of delayed treatment and steps being taken to mitigate infection risks. Dr Cappuzzo also highlights data from a study investigating the efficacy of canakinumab and a study of the COVID-19 risk in patients with breast cancer who are receiving CDK4/6 inhibitors. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.